HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Theresa L Whiteside Selected Research

Muromonab-CD3 (Muromonab CD3)

12/2011Expression of IL-10 and IL-10 receptors on peripheral blood lymphocytes and monocytes in human head and neck squamous cell carcinoma.
6/2010Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).
2/2009Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Theresa L Whiteside Research Topics

Disease

172Neoplasms (Cancer)
01/2022 - 02/2002
50Squamous Cell Carcinoma of Head and Neck
08/2021 - 06/2002
26Head and Neck Neoplasms (Head and Neck Cancer)
11/2020 - 04/2002
20Melanoma (Melanoma, Malignant)
10/2021 - 07/2002
9Glioma (Gliomas)
01/2022 - 08/2003
9Disease Progression
06/2021 - 06/2008
9Carcinoma (Carcinomatosis)
01/2018 - 12/2002
8Neoplasm Metastasis (Metastasis)
01/2019 - 02/2003
7Breast Neoplasms (Breast Cancer)
07/2021 - 01/2003
7Leukemia
01/2019 - 01/2015
6Inflammation (Inflammations)
04/2022 - 01/2007
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2013 - 01/2005
5Carcinogenesis
12/2019 - 03/2005
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2017 - 01/2010
5Infections
12/2015 - 10/2004
5Ovarian Neoplasms (Ovarian Cancer)
03/2012 - 08/2003
4Human Influenza (Influenza)
08/2012 - 06/2002
3Lymphatic Metastasis
06/2020 - 05/2006
3Glioblastoma (Glioblastoma Multiforme)
06/2020 - 08/2003
2Lung Neoplasms (Lung Cancer)
10/2020 - 03/2003
2Pathologic Complete Response
08/2020 - 05/2009
2Lymphoma (Lymphomas)
01/2020 - 04/2016
2Viremia
05/2016 - 02/2008
2Residual Neoplasm
01/2016 - 11/2007
2Colorectal Neoplasms (Colorectal Cancer)
01/2014 - 01/2013
2Squamous Cell Neoplasms (Squamous Cell Cancer)
06/2012 - 06/2012

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2002
32Biomarkers (Surrogate Marker)IBA
04/2022 - 02/2003
31AntigensIBA
01/2021 - 03/2002
31Peptides (Polypeptides)IBA
09/2017 - 02/2002
26CytokinesIBA
01/2018 - 02/2003
26VaccinesIBA
05/2016 - 07/2002
23EpitopesIBA
07/2019 - 02/2002
14Adenosine (Adenocard)FDA LinkGeneric
07/2021 - 10/2009
12Biological ProductsIBA
01/2018 - 02/2002
9LigandsIBA
12/2019 - 02/2002
9Interleukin-2 (IL2)IBA
12/2011 - 07/2002
8Cancer VaccinesIBA
01/2016 - 02/2002
7MicroRNAs (MicroRNA)IBA
11/2021 - 04/2016
6AntibodiesIBA
01/2021 - 09/2009
6Messenger RNA (mRNA)IBA
11/2020 - 03/2004
6IRX 2IBA
01/2018 - 04/2011
6Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2017 - 04/2009
6EnzymesIBA
01/2017 - 02/2003
6Interleukin-10 (Interleukin 10)IBA
04/2016 - 09/2007
6Neoplasm Antigens (Tumor Antigens)IBA
05/2014 - 10/2004
6Interleukin-15 (Interleukin 15)IBA
09/2011 - 09/2005
6Fas Ligand Protein (Fas Ligand)IBA
09/2009 - 02/2002
5beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
11/2021 - 01/2013
5Adenosine Triphosphate (ATP)IBA
07/2021 - 09/2010
5Nucleic AcidsIBA
01/2021 - 01/2015
5Protein Subunit VaccinesIBA
07/2019 - 03/2012
5HLA Antigens (Human Leukocyte Antigens)IBA
01/2016 - 04/2005
4Tumor Biomarkers (Tumor Markers)IBA
06/2021 - 11/2009
4Cisplatin (Platino)FDA LinkGeneric
01/2020 - 05/2006
4Small Interfering RNA (siRNA)IBA
11/2019 - 09/2007
4InterferonsIBA
01/2019 - 09/2002
4gallium arsenide (GaAs)IBA
12/2016 - 12/2007
4DNA (Deoxyribonucleic Acid)IBA
04/2016 - 07/2002
4Annexin A5IBA
12/2012 - 01/2003
4Prostaglandins EIBA
02/2012 - 09/2007
4HLA-A*02:01 antigenIBA
11/2007 - 10/2004
4Histocompatibility Antigens Class IIBA
07/2006 - 11/2003
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2006 - 12/2002
3Monoclonal AntibodiesIBA
01/2015 - 07/2009
3Pharmaceutical PreparationsIBA
12/2014 - 07/2003
3Muromonab-CD3 (Muromonab CD3)FDA Link
12/2011 - 02/2009
3Interleukin-5 (Interleukin 5)IBA
09/2009 - 03/2002
3HLA-DR Antigens (HLA-DR)IBA
09/2008 - 02/2006
3HLA-A Antigens (HLA-A)IBA
10/2007 - 12/2005
2Glycoproteins (Glycoprotein)IBA
04/2022 - 07/2012
2ProteomeIBA
01/2021 - 01/2019
24-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA
12/2019 - 11/2018
2Cetuximab (Erbitux)FDA Link
01/2019 - 06/2015
2poly ICLCIBA
01/2016 - 01/2011
2Interleukin-8 (Interleukin 8)IBA
06/2015 - 04/2009
2Lysine (L-Lysine)FDA Link
07/2014 - 01/2011
2Poly I-CIBA
07/2014 - 01/2011
2Carboxymethylcellulose Sodium (Polycell)FDA Link
07/2014 - 01/2011
2Dinoprostone (PGE2)FDA Link
01/2014 - 01/2013
2Protein Isoforms (Isoforms)IBA
12/2012 - 10/2011
2LipopolysaccharidesIBA
12/2011 - 04/2009
2ErbB Receptors (EGF Receptor)IBA
10/2011 - 06/2009
2ProstaglandinsIBA
09/2011 - 09/2007
2Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2011 - 09/2007
2ChemokinesIBA
06/2009 - 05/2006
2NF-kappa B (NF-kB)IBA
04/2009 - 01/2007
2InterleukinsIBA
04/2009 - 12/2007
2Interleukin-4 (Interleukin 4)IBA
12/2007 - 08/2003
2Sirolimus (Rapamycin)FDA Link
12/2007 - 09/2007
2Chemokine ReceptorsIBA
05/2006 - 03/2004
2peptide AIBA
04/2006 - 06/2002

Therapy/Procedure

75Therapeutics
01/2022 - 04/2002
36Immunotherapy
01/2022 - 06/2002
8Drug Therapy (Chemotherapy)
04/2021 - 08/2004
5Radiotherapy
01/2019 - 12/2004
4Biological Therapy
05/2011 - 12/2002
2Art Therapy
05/2016 - 02/2008
2Chemoprevention
02/2013 - 11/2007
2Ligation
04/2009 - 10/2003